{
    "nct_id": "NCT02986867",
    "official_title": "SAbR-Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma",
    "inclusion_criteria": "* Histologic diagnosis of advanced/metastatic urothelial carcinoma, melanoma, or cervical carcinoma.\n* Planned treated with SAbR.\n* Age greater than or equal to 18 years.\n* Lesion to receive SAbR safely accessible for core biopsy-mass >1.5cm diameter and located in node, liver, or soft tissues.\n* Hgb >10g/dL before or after transfusion.\n* Platelets >50,000/L\n* INR <1.5\n* If contrast enhanced CT needed to locate the lesion for core biopsy, then derived creatinine clearance >30cc/min\n* Ability to understand and the willingness to sign a written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior radiation therapy to target lesion.\n* Target lesion not safely accessible for core biopsies.",
    "miscellaneous_criteria": ""
}